跳至主要内容
临床试验/NCT04180566
NCT04180566终止不适用

Does Weekly Antepartum Testing in Women With BMI 30-40 Improve Neonatal Outcomes: A Randomized Controlled Trial

Columbia University1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2020年2月4日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
6
试验地点
1
主要终点
Average gestational age at delivery of participating women's babies

研究概览

简要总结

The purpose of study is to evaluate whether weekly antenatal testing in pregnant women with body mass index (BMI) 30-40 in the third trimester is associated with earlier delivery when compared to growth ultrasounds every 4 weeks. The investigators will also assess the differences in maternal and neonatal outcomes between the groups.

详细描述

Over the last decade, the prevalence of obesity has dramatically increased in women in reproductive age. It is well known that obesity has been associated with increased risk of antenatal complications, maternal and perinatal morbidity, including higher risk of stillbirth. Studies including obese women without other antepartum comorbidities have shown that up to 11% of pregnancies are complicated with fluid and fetal growth abnormalities. According to American College of Obstetricians and Gynecologists (ACOG) guidelines, antepartum surveillance has not been proven to improve pregnancy outcomes in such cases and no specific recommendations for antepartum surveillance in obese women have been established.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women at or over 18 years of age
  • Singleton pregnancy with no major fetal anomalies
  • Pregnancies and gestational age will be well dated
  • Obese with BMI 30-40kg/m2

排除标准

  • Women with any complications at time of randomization that would require antenatal testing in the third trimester as per ACOG guidelines including: hypertension, systemic lupus erythematosus, chronic renal disease, antiphospholipid syndromes, hyperthyroidism poorly controlled, hemoglobinopathies, cyanotic heart disease, gestational hypertension, pre-eclampsia, gestational diabetes medication controlled, oligohydramnios, intrauterine growth restriction before randomization, isoimmunization, history of fetal demise
  • Women with indication for weekly testing as per local protocol

结局指标

主要结局

Average gestational age at delivery of participating women's babies

时间窗: At time of delivery

This is to measure the number of weeks that the baby has been in the uterus. It is measured from the first day of the woman's last menstrual cycle to the date of delivery. A normal pregnancy can range from 38 to 42 weeks. A significant delay in gestational age of delivery would be \> 7 days out of this range.

次要结局

  • Number of participating women who experienced composite maternal morbidity(At time of delivery)
  • Average birth weight of participating women's babies(At time of delivery)
  • Number of participating women whose babies experienced composite of abnormalities of fluid volume and growth(At time of delivery)
  • Number of participating women whose babies experienced composite neonatal morbidity(At time of delivery)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验